Ultra-small particulates
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
278
NCT03058224
Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia
Phase: N/A
Role: Collaborator
Start: Feb 16, 2017
Completion: Dec 8, 2017
NCT06954428
Clinical Trial of Intranasal Delivery of NT-301
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 20, 2025
Completion: Dec 28, 2025
Loading map...